Home > News > Cell Signaling Technology and Zeptosens AG Enter Agreement
April 19th, 2004
Cell Signaling Technology and Zeptosens AG Enter Agreement
Abstract:
Cell Signaling Technology, Inc. and Zeptosens AG, announced the signing of a supply and license agreement, for the use and resale of certain CST reagents by Zeptosens in conjunction with its ZeptoMARK(TM) protein microarray platform. These reagents include phospho-specific antibodies to key signaling molecules and important therapeutic targets for pharmaceutical drug discovery such as kinases.
Source:
Businesswire
Bookmark:
Investments/IPO's/Splits
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013
Nanometrics Announces Upcoming Investor Events May 14th, 2013
Announcements
How do cold ions slide May 24th, 2013
Heinrich Rohrer dies at 79; a father of nanotechnology: With IBM colleague Gerd Binnig, Rohrer invented the scanning tunneling microscope, which can show individual atoms on a surface and move them around May 23rd, 2013
Gold nanocrystal vibration captured on billion-frames-per-second film May 23rd, 2013
Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home: Glowing Plant seeks funds via crowdfunding and raises almost $400,000 May 23rd, 2013